MULTIPLE MYELOMA IN RELAPSE
Clinical trials for MULTIPLE MYELOMA IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA IN RELAPSE trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to keep relapsed myeloma in check after second transplant
Disease control OngoingThis study tests a combination of three drugs (elotuzumab, pomalidomide, and dexamethasone) given after a second stem cell transplant for people whose multiple myeloma has returned. The goal is to see if this treatment can keep the cancer from progressing for as long as possible.…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 17, 2026 04:29 UTC
-
New hope for Hard-to-Treat myeloma: early trial of HPN217 underway
Disease control OngoingThis early-stage study is testing a new drug called HPN217 (also known as MK-4002) in about 100 people whose multiple myeloma has returned or no longer responds to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how the body process…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1 • Sponsor: Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New drug cocktail shows promise for Tough-to-Treat myeloma
Disease control OngoingThis study tests a combination of three drugs (ixazomib, pomalidomide, and dexamethasone) given twice a week to people with multiple myeloma that has come back or stopped responding to treatment. The goal is to see if this combination can control the cancer and how safe it is. Ab…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1, PHASE2 • Sponsor: Omar Nadeem, MD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy offers hope for hard-to-treat myeloma patients
Disease control OngoingThis study tests a personalized approach using the drug selinexor combined with other medications for people whose multiple myeloma has returned or stopped responding to treatment. 18 participants receive one of three drug combinations chosen by their doctor. The goal is to see h…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Website aims to empower myeloma patients to take charge of their health
Knowledge-focused OngoingThis study looks at whether a health technology program called All4Cure helps people with multiple myeloma become more involved in managing their own health. About 200 participants will fill out surveys over time to measure their confidence and ability to take action, as well as …
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Sponsor: All4Cure • Aim: Knowledge-focused
Last updated May 17, 2026 04:16 UTC